Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

This publication has 34 references indexed in Scilit:

• Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
  Vaccine, 2008
• Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines
  Journal of Virology, 2007
• Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis
  The Lancet, 2006
• Prevention and Treatment of Influenza in High‐Risk Groups: Children, Pregnant Women, Immunocompromised Hosts, and Nursing Home Residents
  The Journal of Infectious Diseases, 2006
• The Safety of Trivalent Influenza Vaccine Among Healthy Children 6 to 24 Months of Age
  Pediatrics, 2006
• Mitigation strategies for pandemic influenza in the United States
  Proceedings of the National Academy of Sciences, 2006
• Influenza related hospitalisations in Sydney, New South Wales, Australia
  Archives of Disease in Childhood, 2005
• Vaccination strategies for an influenza pandemic.
  The Journal of Infectious Diseases, 2005
• Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine
  Virus Research, 2004
• STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
  The Lancet, 1986